Skip to main content
Contact Us
Subscribe
E-Edition
63°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geron Corp
(NQ:
GERN
)
3.560
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Geron Corp
< Previous
1
2
3
4
5
Next >
Geron (NASDAQ: GERN) Reports Positive Results From IMerge Phase 3 Trial of Imetelstat for Lower Risk MDS
January 04, 2023
Geron Corporation (NASDAQ: GERN) is engaged as a late-stage biopharmaceutical company, which is focused on the research and development of
Via
Spotlight Growth
Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS
January 04, 2023
From
Geron Corporation
Via
Business Wire
Geron Announces Conference Call for Top-Line Results from IMerge Phase 3
January 03, 2023
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 22, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Oral Presentation at ASH Annual Meeting Highlighting Continuous Long-Term Transfusion Independence with Imetelstat Treatment in Lower Risk MDS Patients
December 12, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2022
From
Geron Corporation
Via
Business Wire
Geron to Participate in Stifel 2022 Healthcare Conference
November 07, 2022
From
Geron Corporation
Via
Business Wire
Geron Announces Presentations at Upcoming ASH Annual Meeting Including Long-term Phase 2 Data Showing Continuous Durable Transfusion Independence in Patients with Lower Risk MDS
November 03, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones
November 03, 2022
From
Geron Corporation
Via
Business Wire
Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022
October 27, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 20, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 22, 2022
From
Geron Corporation
Via
Business Wire
Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors
September 08, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at Upcoming Investor Conferences
September 01, 2022
From
Geron Corporation
Via
Business Wire
Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis
August 22, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Second Quarter 2022 Financial Results
August 11, 2022
From
Geron Corporation
Via
Business Wire
Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022
August 04, 2022
From
Geron Corporation
Via
Business Wire
Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
August 03, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Expansion of Existing Loan Facility
June 30, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role
June 15, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at the H.C. Wainwright Global Investment Conference
May 17, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports First Quarter 2022 Financial Results
May 09, 2022
From
Geron Corporation
Via
Business Wire
Geron to Announce First Quarter 2022 Financial Results on May 9, 2022
May 02, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 21, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at the 21st Annual Needham Virtual Healthcare Conference
April 06, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
April 01, 2022
From
Geron Corporation
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.